Sentences with phrase «translational immunology research»
A sampling of presentations will highlight opportunities in reverse translational immunology research.
http://www.immunology2018.org/ Not exact matches
publishes basic, translational and clinical research specifically about immunology across all organisms and model systems, including humans.
Focusing on basic research for the functional regulation of innate and adaptive immunity and on translational research for cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology immunology community.
Watkins and Dennis Burton, Ph.D., chairman and professor of the Department of Immunology & Microbiology at the Scripps Research Institute, led the collaborative international study, «Neutralizing Human Monoclonal Antibodies Prevents Zika Virus Infection in Macaques,» published recently in Science Translational Medicine.
Together with the Director of the Institute of Translational Immunology, Professor Detlef Schuppan, Schattenberg is leading the LIFT - off (Lifestyle Intervention to prevent and improve hepatic fibrosis in non-alcoholic fatty liver disease) research initiative.
At the dinner, Parker also received the organization's highest honor for lay individuals, the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research, for his outspoken endorsement of cancer immunotherapy and substantial financial support of the Cancer Immunology Translational Research Dream Team that is jointly funded by CRI and Stand Up To Cancer, an organization to which Parker has strong ties.
The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.
While translational research has traditionally moved basic immunology knowledge forward into clinical application, varying clinical presentations of human immune - related disease processes, as well as variability in therapeutic outcomes, have provided opportunities for discovery of novel mechanistic hypotheses directly from patients.
Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.
In addition, our basic science and translational research efforts — particularly in the areas of the gut microbiome, immunology, and microbiology — are contributing to the scientific advancement in the development, prevention, and treatment of IBD, and to the promise of more effective treatment strategies for future patients.
Special emphasis is given to research in the areas of integrative neuro - sciences, medical imaging, translational immunology and cancer research, microbiology and infection research, biochemistry and pharmaceutical research, plant molecular biology, geo - and environmental research, astro - and elementary particle physics, quantum physics and nanotechnology, archeology and prehistory, historical science, religion and cultures, language and cognition, media and educational research.
Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - ViralResearch, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viralresearch, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Fascinated by human immunology and translational research, I undertook my PhD in tumor immunology at the University of Tuebingen (Germany).
Promoting and disseminating research and good practice in immunology, translational medicine and vaccination
Warner Greene's primary affiliation is with the Gladstone Institute of Virology and Immunology, where he is director and the Nick and Sue Hellman Distinguished Professor of Translational Medicine and where his laboratory is located and his research is conducted.
In 2006, I crossed the English Channel to go learn more about human immunology and translational research in Southampton (Pr.
Elizabeth Winzeler, PhD Professor of Pediatrics, Division of Pharmacology and Drug Discovery University of California, San Diego, School of Medicine Director of Translational Research, UC Health Sciences Center for Immunology, Infection and Inflammation Talk title: Using chemical genomics to find new targets for malaria elimination
In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., program leader of Wistar's Translational Tumor Immunology program, and his research team identified a marker for myeloid - derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.
JAX has particular strengths in research focused on understanding aging, behavior and addiction, computational biology, cancer, development and disease, gene expression, genetics and genomics, immunology and hematology, metabolism, microbiome, neuroscience, reproductive biology, statistical and population genetics, stem cells, systems biology, and translational medicine.
She has a Ph.D. in Immunology from Harvard University, and her research interests include targeted therapeutics and translational / comparative oncology.